리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 10월
페이지 정보:영문 93 Pages
라이선스 & 가격 (부가세 별도)
한글목차
심장 매핑 시장은 2030년까지 37억 달러에 도달할 전망입니다.
2023년에 22억 달러로 추정된 심장 매핑 시장은 예측 기간 동안 복합 연간 성장률(CAGR) 7.7%로 성장하고 2030년에는 37억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 심방세동적응증은 복합 연간 성장률(CAGR) 7.1%로 성장을 지속하고, 분석 기간 종료까지 12억 달러에 달할 것으로 예측됩니다. 심방 조동 적응증 분야의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 8.5%로 추정됩니다.
미국 시장은 5억 7,700만 달러로 추정되며 중국은 복합 연간 성장률(CAGR) 11.5%로 성장할 것으로 예측됩니다.
미국의 심장 매핑 시장은 2023년 5억 7,700만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 예측 기간 동안 복합 연간 성장률(CAGR) 11.5%를 견인해 2030년에는 예측시장 규모 9억980만 달러에 달할 것으로 예측되고 있습니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR)은 각각 4.0%와 6.7%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 4.6%로 성장할 것으로 예측됩니다.
세계의 심장 매핑 시장- 주요 동향과 촉진요인 정리
심장 매핑이란 무엇이며 왜 현대 심장 병학에 필수적인가?
심장 매핑은 심방 세동, 심실 빈맥 및 기타 비정상적인 심장 리듬과 같은 부정맥을 확인하고 치료하기 위해 심장의 전기적 활동을 시각화하는 데 사용되는 고급 의료 기술입니다. 이 기술을 통해 심장 전문의는 심장 전기 전도 시스템의 상세한 3차원 맵을 작성하고 비정상적인 전기 신호의 발생원에 대한 정확한 정보를 제공할 수 있습니다. 심장 매핑은 부정맥을 일으키는 부위를 핀 포인트로 확인하여 카테터 절제와 같은 치료 개입을 유도하는 데 도움이되며 현대 전기 생리학에서 필수적인 도구가되었습니다.
세계적으로 심혈관 질환(CVD), 특히 부정맥의 유병률이 높아지는 가운데, 심장 매핑과 같은 효과적인 진단, 치료 도구의 필요성이 높아지고 있습니다. 심장 매핑이 제공하는 정확도는 보다 정확한 진단을 가능하게 하고, 효과가 없는 치료의 위험을 줄이고, 치료 침습을 최소화합니다. 또한, 심장 매핑은 기존의 진단 방법에서 부정맥의 근본 원인을 확인하기에 충분하지 않은 복잡한 경우에 사용되는 경우가 많습니다. 이러한 진보된 진단에 대한 의존성이 증가함에 따라 심장 매핑은 심장 치료에 필수적입니다.
기술의 진보는 심장 매핑 시장을 어떻게 형성합니까?
기술의 진보는 심장 매핑 시장에 혁명을 가져오고, 더 정교하고 정확하고 사용자 친화적인 시스템의 개발로 이어지고 있습니다. 3차원(3D) 전기 해부학적 매핑 시스템의 소개는 의사가 실시간으로 심장의 전기 경로를 시각화하는 능력을 크게 향상시켰습니다. 이 시스템은 카테터, 센서, 이미지 모달리티 등 다양한 소스의 데이터를 통합하고 매우 상세한 맵을 만들어 개입을 놀라울 정도로 정확하게 유도합니다. 예를 들어, CARTO 3 시스템과 EnSite Precision 시스템과 같은 시스템은 복잡한 부정맥 진단 및 치료 방법을 변경했습니다.
게다가, 바디 표면 매핑(BSM)과 같은 비침습적 매핑 기술의 진보는 침습적인 카테터 치료 없이 심층 매핑을 가능하게 하고 인기를 끌고 있습니다. 이는 환자의 편안함을 향상시킬 뿐만 아니라 조기 진단 및 경과 관찰에서 매핑의 적용 범위를 확장합니다. 인공지능(AI)과 머신러닝 알고리즘의 상승은 신호 해석의 정확성을 향상시켜 심장 매핑 능력을 더욱 향상시키고 보다 빠르고 정확한 진단을 가능하게 합니다. 이러한 기술 혁신으로 심장 매핑은 보다 효율적이고 이용하기 쉽고, 임상 현장에서의 가치가 높아지고, 세계의 병원이나 심장 전문센터에서의 채용이 진행되고 있습니다.
어떤 환자와 헬스케어 동향이 심장 매핑에 대한 수요를 견인하고 있는가?
심장 매핑 기술 수요에는 여러 환자 동향과 헬스케어 동향이 영향을 미칩니다. 심혈관 질환, 특히 부정맥 발생률 증가는 주요 촉진요인 중 하나입니다. 세계 인구의 고령화, 고혈압, 비만, 앉기 쉬운 라이프 스타일 등의 위험 인자 증가로 심장 리듬 장애의 유병률이 증가하는 경향이 있습니다. 심방 세동이나 심실 빈맥과 같은 질병으로 진단받는 환자가 증가함에 따라 정확하고 효과적인 치료법을 제공하는 고급 진단 도구의 필요성이 높아지고 심장 매핑 시스템에 대한 의존도가 높아지고 있습니다.
또 다른 중요한 동향은 맞춤형 의료가 중요하다는 것입니다. 오늘날의 환자는 특정 병리학에 대응하는보다 맞춤형 치료를 기대합니다. 심장 매핑은 부정맥의 원인을 정확하게 확인하고 심장의 특정 부위를 치료 대상으로 함으로써 순환기 전문의가 맞춤형 치료를 제공할 수 있게 합니다. 또한 회복 시간 단축, 통증 경감, 합병증 감소 등 환자의 취향에 힘입어 저침습 치료에 대한 수요가 높아지고 있습니다. 심장 매핑, 특히 가이딩 카테터 절제는 부정맥 치료를위한 낮은 침습이지만 매우 효과적인 솔루션을 제공함으로써이 동향과 일치합니다. 환자의 기대와 헬스케어 제공의 진화에 따라 심장 매핑과 같은 정밀 진단에 대한 수요는 계속 확대되고 있습니다.
심장 매핑 시장의 성장은 여러 요인별로 가져옵니다.
심장 매핑 시장의 성장은 심혈관 질환의 유병률 증가, 전기 생리학적 기술의 진보, 낮은 침습 수술에 대한 수요 증가 등 여러 요인에 의해 야기됩니다. 주요 촉진요인 중 하나는 부정맥 및 기타 심장 리듬 장애로 진단되는 환자 수 증가입니다. 특히 생활습관이나 고령화로 인해 부정맥 환자가 세계적으로 증가하는 가운데 심장 전문의가 심장의 전기적 활동을 정확하게 매핑하고 정확한 치료를 하기 위한 효과적인 진단 도구의 필요성이 높아지고 있습니다.
심장 매핑 시스템의 기술적 진보도 시장 성장을 뒷받침하고 있습니다. 3D 전기 해부학 맵핑 시스템, 비침습적 신체 표면 맵핑 및 인공지능이 있는 진단 도구의 개발은 부정맥 진단 및 치료의 정확성과 효율성을 향상시킵니다. 이러한 기술 혁신을 통해 심장 매핑 시스템은 병원 및 전문센터에서 더 쉽게 사용할 수 있게 되어 시장이 더욱 확대되고 있습니다. 게다가 부정맥 치료에 사용되는 낮은 침습 절차인 카테터 절제의 채용이 증가하고 있는 것도 이러한 절차를 고정밀 도로 안내하는 심장 매핑 기술 수요를 끌어올리고 있습니다.
또한, 맞춤형 의료나 정밀의료에 대한 주목이 높아지고 있는 것도 시장 성장을 뒷받침하는 중요한 요인이 되고 있습니다. 심장 매핑을 사용하면 환자 한 사람의 심장 상태에 따라 치료 전략이 가능하므로 치료 성적이 향상되고 재수술의 필요성이 줄어듭니다. 또한 세계 헬스케어 시스템이 환자 관리 개선과 심혈관 질환 부담 완화에 중점을두고있는 동안 심장 매핑은보다 효과적이고 개별화 된 심장 관리를 제공하는 데 중요한 도구입니다. 이러한 동향은 향후 수년간 심장 매핑 시장의 성장에 박차를 가할 것으로 예상됩니다.
조사 대상 기업 예(총 42건)
Abbott Laboratories
Acutus Medical
Angiodynamics
APN Health, LLC
Biosense Webster, Inc.(A Johnson & Johnson Company)
Biosig Technologies, Inc.
Biotronik
Boston Scientific Corporation
Catheter Precision, Inc.
Coremap
EP Solutions Sa
Epmap-System
Kardium, Inc.
Koninklijke Philips NV
Lepu Medical
Medtronic Plc
Microport Scientific Corporation
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트(UAE)
기타 중동
아프리카
제4장 경쟁
BJH
영문 목차
영문목차
Global Cardiac Mapping Market to Reach US$3.7 Billion by 2030
The global market for Cardiac Mapping estimated at US$2.2 Billion in the year 2023, is expected to reach US$3.7 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Atrial Fibrillation Indication, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Atrial Flutter Indication segment is estimated at 8.5% CAGR over the analysis period.
The U.S. Market is Estimated at US$577.0 Million While China is Forecast to Grow at 11.5% CAGR
The Cardiac Mapping market in the U.S. is estimated at US$577.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$909.8 Million by the year 2030 trailing a CAGR of 11.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.0% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.
Global Cardiac Mapping Market – Key Trends & Drivers Summarized
What Is Cardiac Mapping and Why Is It Essential in Modern Cardiology?
Cardiac mapping is an advanced medical technique used to visualize the electrical activity of the heart to identify and treat arrhythmias, such as atrial fibrillation, ventricular tachycardia, and other abnormal heart rhythms. This technique allows cardiologists to create detailed, three-dimensional maps of the heart’s electrical conduction system, offering precise information about the source of abnormal electrical signals. By pinpointing the locations responsible for arrhythmias, cardiac mapping helps guide therapeutic interventions such as catheter ablation, making it an essential tool in modern electrophysiology.
With the rising prevalence of cardiovascular diseases (CVDs) globally, particularly arrhythmias, the need for effective diagnosis and treatment tools like cardiac mapping is growing. The precision that cardiac mapping provides allows for more accurate diagnoses, reducing the risk of ineffective treatments and minimizing the invasiveness of procedures. Additionally, cardiac mapping is increasingly used in complex cases where traditional diagnostic methods may not be sufficient to determine the root cause of the arrhythmia. This growing reliance on sophisticated diagnostics is making cardiac mapping an indispensable part of cardiac care.
How Are Technological Advancements Shaping the Cardiac Mapping Market?
Technological advancements are revolutionizing the cardiac mapping market, leading to the development of more sophisticated, accurate, and user-friendly systems. The introduction of three-dimensional (3D) electroanatomical mapping systems has significantly enhanced the ability of physicians to visualize the heart's electrical pathways in real-time. These systems integrate data from various sources, such as catheters, sensors, and imaging modalities, to generate highly detailed maps that guide interventions with remarkable precision. For example, systems like the CARTO 3 system and the EnSite Precision system have transformed the way complex arrhythmias are diagnosed and treated.
Moreover, advancements in non-invasive mapping technologies, such as body surface mapping (BSM), are gaining traction as they allow for detailed cardiac mapping without the need for invasive catheterization. This not only improves patient comfort but also broadens the application of mapping in early diagnosis and follow-up care. The rise of artificial intelligence (AI) and machine learning algorithms is further enhancing the capabilities of cardiac mapping by improving the accuracy of signal interpretation, enabling faster and more accurate diagnoses. These technological innovations are making cardiac mapping more efficient, accessible, and valuable in clinical practice, driving its adoption in hospitals and specialized cardiac centers worldwide.
What Patient and Healthcare Trends Are Driving the Demand for Cardiac Mapping?
Several patient and healthcare trends are influencing the demand for cardiac mapping technologies. The increasing incidence of cardiovascular diseases, particularly arrhythmias, is one of the primary drivers. With an aging global population and rising risk factors such as hypertension, obesity, and sedentary lifestyles, the prevalence of heart rhythm disorders is on the rise. As more patients are diagnosed with conditions like atrial fibrillation and ventricular tachycardia, the need for advanced diagnostic tools that offer precise and effective treatment options is growing, leading to greater reliance on cardiac mapping systems.
Another key trend is the growing emphasis on personalized medicine. Patients today expect more tailored treatments that cater to their specific medical conditions. Cardiac mapping enables cardiologists to deliver customized therapies by accurately identifying the source of arrhythmias and targeting specific areas of the heart for treatment. Additionally, there is an increasing demand for minimally invasive procedures, driven by patients' preferences for shorter recovery times, reduced pain, and fewer complications. Cardiac mapping, particularly in guiding catheter ablation, aligns with this trend by offering a minimally invasive yet highly effective solution for treating arrhythmias. As patient expectations and healthcare delivery evolve, the demand for precision diagnostics like cardiac mapping continues to grow.
Growth in the Cardiac Mapping Market Is Driven by Several Factors
Growth in the cardiac mapping market is driven by several factors, including the increasing prevalence of cardiovascular diseases, advancements in electrophysiology technologies, and the rising demand for minimally invasive procedures. One of the key drivers is the growing number of patients diagnosed with arrhythmias and other heart rhythm disorders. As arrhythmia cases rise globally, particularly due to lifestyle factors and aging populations, there is an increasing need for effective diagnostic tools that enable cardiologists to accurately map the heart’s electrical activity and guide precise treatments.
Technological advancements in cardiac mapping systems are also fueling market growth. The development of 3D electroanatomical mapping systems, non-invasive body surface mapping, and AI-powered diagnostic tools is improving the accuracy and efficiency of arrhythmia diagnosis and treatment. These innovations are making cardiac mapping systems more accessible to hospitals and specialized centers, further expanding the market. Additionally, the increasing adoption of catheter ablation, a minimally invasive procedure used to treat arrhythmias, is boosting demand for cardiac mapping technologies that assist in guiding these procedures with high precision.
Another key factor driving market growth is the rising focus on personalized and precision medicine. Cardiac mapping allows for tailored treatment strategies based on the specific characteristics of each patient’s heart condition, improving outcomes and reducing the need for repeat procedures. Furthermore, as healthcare systems worldwide focus on improving patient care and reducing the burden of cardiovascular diseases, cardiac mapping is becoming a crucial tool in providing more effective and personalized cardiac care. These trends are expected to continue fueling the growth of the cardiac mapping market in the coming years.
Select Competitors (Total 42 Featured) -
Abbott Laboratories
Acutus Medical
Angiodynamics
APN Health, LLC
Biosense Webster, Inc. (A Johnson & Johnson Company)
Biosig Technologies, Inc.
Biotronik
Boston Scientific Corporation
Catheter Precision, Inc.
Coremap
EP Solutions Sa
Epmap-System
Kardium, Inc.
Koninklijke Philips N.V.
Lepu Medical
Medtronic Plc
Microport Scientific Corporation
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Cardiac Mapping - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Prevalence of Cardiovascular Diseases Globally Drives Demand for Advanced Cardiac Mapping Solutions in Diagnosis and Treatment
Increasing Demand for Minimally Invasive Cardiac Procedures Strengthens Market Position of Advanced Cardiac Mapping Technologies
Technological Advancements in 3D Mapping and Real-Time Visualization Propel Adoption of Cardiac Mapping in Electrophysiology
Growing Focus on Personalized Medicine and Precision Cardiology Expands Addressable Market for Cardiac Mapping Solutions
Rising Adoption of Cardiac Mapping in Atrial Fibrillation Treatment Creates New Growth Opportunities in Cardiology
Improving Accuracy and Resolution in Mapping Systems Drives Demand for High-Definition Cardiac Mapping in Complex Arrhythmias
Growing Integration of Cardiac Mapping with Robotic-Assisted Catheter Navigation Enhances Precision in Cardiac Interventions
Increasing Number of Cardiac Electrophysiology Labs and Specialty Clinics Expands Market Potential for Cardiac Mapping Systems
Rising Patient Awareness of Arrhythmia Risks and Treatments Drives Demand for Non-Invasive Cardiac Mapping Technologies
Development of Portable and Wearable Mapping Solutions for Continuous Monitoring Spurs Growth in Home and Outpatient Cardiac Care
Growing Use of Artificial Intelligence in Mapping Algorithms Enhances Efficiency and Predictive Capabilities of Cardiac Mapping Systems
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Cardiac Mapping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Cardiac Mapping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Cardiac Mapping by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Atrial Fibrillation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Atrial Fibrillation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Atrial Fibrillation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Atrial Flutter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Atrial Flutter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Atrial Flutter by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for AVNRT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for AVNRT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for AVNRT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Other Arrhythmias by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Other Arrhythmias by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Other Arrhythmias by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Contact Cardiac Mapping Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Contact Cardiac Mapping Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Contact Cardiac Mapping Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Non-Contact Cardiac Mapping Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Non-Contact Cardiac Mapping Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Non-Contact Cardiac Mapping Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 22: World Cardiac Mapping Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 23: USA Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 24: USA Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: USA 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 27: USA Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: USA 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
CANADA
TABLE 29: Canada Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: Canada 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 32: Canada Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: Canada Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: Canada 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
JAPAN
Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 35: Japan Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: Japan 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 38: Japan Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: Japan Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: Japan 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
CHINA
Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 41: China Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: China Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: China 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 44: China Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: China Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: China 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
EUROPE
Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 47: Europe Recent Past, Current & Future Analysis for Cardiac Mapping by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Cardiac Mapping by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Europe 16-Year Perspective for Cardiac Mapping by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: Europe 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 53: Europe Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Europe 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
FRANCE
Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 56: France Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: France Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: France 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 59: France Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: France Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: France 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
GERMANY
Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 62: Germany Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: Germany 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 65: Germany Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: Germany Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: Germany 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
ITALY
TABLE 68: Italy Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Italy 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 71: Italy Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: Italy Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Italy 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
UNITED KINGDOM
Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 74: UK Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: UK Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: UK 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 77: UK Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: UK Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: UK 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
SPAIN
TABLE 80: Spain Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Spain Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Spain 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 83: Spain Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: Spain Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: Spain 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
RUSSIA
TABLE 86: Russia Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Russia Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Russia 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 89: Russia Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Russia Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Russia 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Rest of Europe 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Rest of Europe Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Rest of Europe 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Mapping by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Cardiac Mapping by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Asia-Pacific 16-Year Perspective for Cardiac Mapping by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Asia-Pacific 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: Asia-Pacific 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
AUSTRALIA
Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 107: Australia Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Australia Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Australia 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 110: Australia Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: Australia Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: Australia 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
INDIA
Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 113: India Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: India Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: India 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 116: India Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: India Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: India 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 119: South Korea Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: South Korea Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: South Korea 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 122: South Korea Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: South Korea Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: South Korea 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: Rest of Asia-Pacific Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 129: Rest of Asia-Pacific Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
LATIN AMERICA
Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 131: Latin America Recent Past, Current & Future Analysis for Cardiac Mapping by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 132: Latin America Historic Review for Cardiac Mapping by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: Latin America 16-Year Perspective for Cardiac Mapping by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 134: Latin America Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 135: Latin America Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Latin America 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 137: Latin America Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 138: Latin America Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Latin America 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 140: Argentina Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 141: Argentina Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 142: Argentina 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 143: Argentina Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 144: Argentina Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 145: Argentina 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
BRAZIL
TABLE 146: Brazil Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 147: Brazil Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 148: Brazil 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 149: Brazil Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 150: Brazil Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 151: Brazil 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
MEXICO
TABLE 152: Mexico Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 153: Mexico Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 154: Mexico 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 155: Mexico Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 156: Mexico Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 157: Mexico 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 159: Rest of Latin America Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 160: Rest of Latin America 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 162: Rest of Latin America Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 163: Rest of Latin America 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
MIDDLE EAST
Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 164: Middle East Recent Past, Current & Future Analysis for Cardiac Mapping by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 165: Middle East Historic Review for Cardiac Mapping by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 166: Middle East 16-Year Perspective for Cardiac Mapping by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 167: Middle East Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 168: Middle East Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 169: Middle East 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 170: Middle East Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 171: Middle East Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 172: Middle East 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
IRAN
TABLE 173: Iran Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 174: Iran Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 175: Iran 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 176: Iran Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 177: Iran Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 178: Iran 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
ISRAEL
TABLE 179: Israel Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 180: Israel Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 181: Israel 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 182: Israel Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 183: Israel Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 184: Israel 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 186: Saudi Arabia Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 187: Saudi Arabia 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 189: Saudi Arabia Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 190: Saudi Arabia 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 191: UAE Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 192: UAE Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 193: UAE 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 194: UAE Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 195: UAE Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 196: UAE 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 198: Rest of Middle East Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 199: Rest of Middle East 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 201: Rest of Middle East Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 202: Rest of Middle East 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
AFRICA
Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 203: Africa Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 204: Africa Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 205: Africa 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
TABLE 206: Africa Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 207: Africa Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 208: Africa 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030